First stages of safety cleared this week. Before AGN announces their final result NYR will have completed safety. AGN shows any signs of efficacy means the mechanism of action of inhibiting calcium to protect the brain is proven. However still believe AGN will fail or show minimal efficacy because its drug class have failed before due to the below reason and NYR voids this problem all together with its drug. Either way NYR benefits from either result. Still a rubbish market cap of 20 million. Things will change
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.010(5.00%) |
Mkt cap ! $44.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 20.0¢ | $117.0K | 569.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 116648 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 170902 | 3 |
View Market Depth
| Last trade - 10.43am 17/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |